New Science Ventures

Funding rounds backed by New Science Ventures.

Export CSV
Funding disclosed in full
$9M
Median round
$9M
Rounds in calculation
1
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Trellis Bioscience

Developing native human monoclonal antibodies to treat intractable infectious diseases

$9MSeries CBiotechUnited States
4 participantsAMR Action FundEaston CapitalNew Science VenturesThe Doctor Group